Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure

Hypertension

Volumn 59, Issue 3, 2012, Pages 634-641

  Ramchandra, Rohit ^a   Hood, Sally G ^a   Watson, Anna M D ^a   Allen, Andrew M ^a   May, Clive N ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

angiotensin; cardiac sympathetic nerve activity; heart failure; losartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; CANDESARTAN; LOSARTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA POSTREMA; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; FEMALE; HEART BEAT; HEART EJECTION FRACTION; HEART FAILURE; HEART NERVE; HEART RATE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; KIDNEY NERVE; MEAN ARTERIAL PRESSURE; NERVE CONDUCTION; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SHEEP; SOLITARY TRACT NUCLEUS; SUPRAOPTIC NUCLEUS; SYMPATHETIC NERVE;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; AUTORADIOGRAPHY; BAROREFLEX; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART; HEART FAILURE; HEART RATE; INFUSIONS, INTRAVENOUS; KIDNEY; LOSARTAN; SHEEP; SYMPATHETIC NERVOUS SYSTEM;

EID: 84857639755     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.181131     Document Type: Article

References (46)

1. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension. 1988;11:3-20. (Pubitemid 18086305)
2. Garg R, Yusuf S. Overview of randomized trials of angiotensinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure: Collaborative Group on ACE Inhibitor Trials. JAMA. 1995; 273:1450-1456.
3. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316:1429-1435.
4. CIBIS Investigators and Committees. A randomized trial of -blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 1994;90:1765-1773.
5. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Morton Hawkins C, on behalf of the SAFE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992;327:669-677.
6. Liang C, Rounds NK, Dong E, Stevens SY, Shite J, Qin F. Alterations by norepinephrine of cardiac sympathetic nerve terminal function and myocardial -adrenergic receptor sensitivity in the ferret: normalization by antioxidant vitamins. Circulation. 2000;102:96-103. (Pubitemid 30430559)
7. Briest W, Holzl A, Rassler B, Deten A, Leicht M, Baba HA, Zimmer HG. Cardiac remodeling after long term norepinephrine treatment in rats. Cardiovas Res. 2001;52:265-273. (Pubitemid 33000403)
8. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
9. Woodley SL, Gilbert EM, Anderson JL, O'Connell JB, Deitchman D, Yanowitz FG, Mealey PC, Volkman K, Renlund DG, Menlove R. -Blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:2426-2441.
10. DiBona GF, Jones SY, Brooks VL. ANG II receptor blockade and arterial baroreflex regulation of renal nerve activity in cardiac failure. Am J Physiol Regul Comp Integr Physiol. 1995;269:R1189-R1196. (Pubitemid 3006002)
11. Francis J, Wei SG, Weiss RM, Felder RB. Brain angiotensin-converting enzyme activity and autonomic regulation in heart failure. Am J Physiol Heart Circ Physiol. 2004;287:H2138-H2146. (Pubitemid 39430754)
12. Murakami H, Liu JL, Zucker IH. Angiotensin II blockade [corrected] enhances baroreflex control of sympathetic outflow in heart failure. Hypertension. 1997;29:564-569. (Pubitemid 27074719)
13. Patel KP. Role of paraventricular nucleus in mediating sympathetic outflow in heart failure. Heart Fail Rev. 2000;5:73-86. (Pubitemid 30301512)
14. Leimbach WN Jr, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73: 913-919. (Pubitemid 16102181)
15. Macefield VG, Rundqvist B, Sverrisdottir YB, Wallin BG, Elam M. Firing properties of single muscle vasoconstrictor neurons in the sympathoexcitation associated with congestive heart failure. Circulation. 1999; 100:1708-1713. (Pubitemid 29485253)
16. Boscan P, Allen AM, Paton JF. Baroreflex inhibition of cardiac sympathetic outflow is attenuated by angiotensin II in the nucleus of the solitary tract. Neuroscience. 2001;103:153-160. (Pubitemid 32304355)
17. Saigusa T, Iriki M, Arita J. Brain angiotensin II tonically modulates sympathetic baroreflex in rabbit ventrolateral medulla. Am J Physiol Heart Circ Physiol. 1996;271:H1015-H1021.
18. Zhang W, Huang BS, Leenen FH. Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction. Am J Physiol Heart Circ Physiol. 1999;276:H1608-H1615. (Pubitemid 29246548)
19. Ramchandra R, Hood SG, Denton DA, Woods RL, McKinley MJ, McAllen RM, May CN. Basis for the preferential activation of cardiac sympathetic nerve activity in heart failure. Proc Natl Acad Sci. 2009;106: 924-928.
20. Ramchandra R, Hood SG, Frithiof R, May CN. Discharge properties of cardiac and renal sympathetic nerves and their impaired responses to changes in blood volume in heart failure. Am J Physiol Regul Integr Comp Physiol. 2009;297:R665-R674.
21. Ramchandra R, Hood SG, Watson AM, May CN. Responses of cardiac sympathetic nerve activity to changes in circulating volume differ in normal and heart failure sheep. Am J Physiol Regul Integr Comp Physiol. 2008;295:R719-R726.
22. May CN, McAllen RM. Baroreceptor-independent renal nerve inhibition by intracerebroventricular angiotensin II in conscious sheep. Am J Physiol Regul Integr Comp Physiol. 1997;273:R560-R567.
23. Watson AM, Mogulkoc R, McAllen RM, May CN. Stimulation of cardiac sympathetic nerve activity by central angiotensinergic mechanisms in conscious sheep. Am J Physiol Regul Integr Comp Physiol. 2004;286: R1051-R1056. (Pubitemid 38661392)
24. Watson AM, Hood SG, Ramchandra R, McAllen RM, May CN. Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex. Am J Physiol Heart Circ Physiol. 2007;293:H798-H804. (Pubitemid 47105144)
25. McKinley MJ, Allen A, Clevers J, Denton DA, Mendelsohn FA. Autoradiographic localization of angiotensin receptors in the sheep brain. Brain Res. 1986;375:373-376. (Pubitemid 16078058)
26. May CN, Frithiof R, Hood SG, McAllen RM, McKinley MJ, Ramchandra R. Specific control of sympathetic nerve activity to the mammalian heart and kidney. Exp Physiol. 2010;95:34-40.
27. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation. 1997;95:169-175. (Pubitemid 27029959)
28. Al-Hesayen A, Parker JD. Impaired baroreceptor control of renal sympathetic activity in human chronic heart failure. Circulation. 2004;109: 2862-2865. (Pubitemid 38780299)
29. Petersson M, Friberg P, Eisenhofer G, Lambert G, Rundqvist B. Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure. Eur Heart J. 2005;26:906-913. (Pubitemid 40676571)
30. Gao L, Wang W, Li YL, Schultz HD, Liu D, Cornish KG, Zucker IH. Sympathoexcitation by central ANG II: roles for AT1 receptor upregulation and NAD(P)H oxidase in RVLM. Am J Physiol Heart Circ Physiol. 2005;288:H2271-H2279. (Pubitemid 40604115)
31. Chen JS, Wang W, Bartholet T, Zucker IH. Analysis of baroreflex control of heart rate in conscious dogs with pacing-induced heart failure. Circulation. 1991;83:260-267.
32. Ellenbogen KA, Mohanty PK, Szentpetery S, Thames MD. Arterial baroreflex abnormalities in heart failure: reversal after orthotopic cardiac transplantation. Circulation. 1989;79:51-58. (Pubitemid 19043674)
33. Wang W, Ma R. Cardiac sympathetic afferent reflexes in heart failure. Heart Fail Rev. 2000;5:57-71. (Pubitemid 30301511)
34. Liu D, Gao L, Roy SK, Cornish KG, Zucker IH. Neuronal angiotensin II type 1 receptor upregulation in heart failure: activation of activator protein 1 and Jun N-terminal kinase. Circ Res. 2006;99:1004-1011. (Pubitemid 44657804)
35. Tan J, Wang H, Leenen FH. Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in rats. Am J Physiol Heart Circ Physiol. 2004;286:H1665-H1671. (Pubitemid 38525452)
36. Yoshimura R, Sato T, Kawada T, Shishido T, Inagaki M, Miyano H, Nakahara T, Miyashita H, Takaki H, Tatewaki T, Yanagiya Y, Sugimachi M, Sunagawa K. Increased brain angiotensin receptor in rats with chronic high-output heart failure. J Card Fail. 2000;6:66-72. (Pubitemid 30161419)
37. Lee WB, Lumbers ER. Angiotensin and the cardiac baroreflex response to phenylephrine. Clin Exp Pharmacol Physiol. 1981;8:109-117. (Pubitemid 11153933)
38. Matsukawa S, Reid IA. Role of the area postrema in the modulation of the baroreflex control of heart rate by angiotensin II. Circ Res. 1990;67: 1462-1473.
39. Casto R, Phillips MI. Angiotensin II attenuates baroreflexes at nucleus tractus solitarius of rats. Am J Physiol Regul Integr Comp Physiol. 1986;250:R193-R198.
40. Shoji M, Share L, Crofton JT. Effect on vasopressin release of microinjection of angiotensin II into the paraventricular nucleus of conscious rats. Neuroendocrinology. 1989;50:327-333. (Pubitemid 19226828)
41. Tsushima H, Mori M, Matsuda T. Microinjections of angiotensin II into the supraoptic and paraventricular nuclei produce potent antidiureses by vasopressin release mediated through adrenergic and angiotensin receptors. Jpn J Pharmacol. 1994;66:241-246. (Pubitemid 24357106)
42. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FA, Chai SY. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol. 2003; 35:901-918. (Pubitemid 36379330)
43. McKinley MJ, Allen AM, Mathai ML, May C, McAllen RM, Oldfield BJ, Weisinger RS. Brain angiotensin and body fluid homeostasis. Jpn J Physiol. 2001;51:281-289.
44. Goldsmith SR, Francis GS, Cowley AW Jr, Levine TB, Cohn JN. Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol. 1983;1:1385-1390. (Pubitemid 13054124)
45. Ramchandra R, Watson AM, Hood SG, May CN. Response of cardiac sympathetic nerve activity to intravenous irbesartan in heart failure. Am J Physiol Regul Integr Comp Physiol. 2010;298:R1056-R1060.
46. Kasama S, Toyama T, Kumakura H, Takayama Y, Ichikawa S, Suzuki T, Kurabayashi M. Effects of candesartan on cardiac sympathetic nerve activity in patients with congestive heart failure and preserved left ventricular ejection fraction. J Am Coll Cardiol. 2005;45:661-667. (Pubitemid 40278963)